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Many cystic fibrosis (CF) airway infections are considered to be polymicrobial and
microbe–microbe interactions may play an important role in disease pathology.
Pseudomonas aeruginosa and Aspergillus fumigatus are the most prevalent bacterial
and fungal pathogens isolated from the CF airway, respectively. We have previously
shown that patients co-colonized with these pathogens had comparable outcomes
to those chronically colonized with P. aeruginosa. Our objective was to examine the
interactions between A. fumigatus and P. aeruginosa, specifically the effects of co-
colonization on biofilm formation, virulence and host pro-inflammatory responses. Our
findings suggest that co-infections of A. fumigatus and P. aeruginosa in the Galleria
mellonella acute infection model showed that pre-exposure of larvae to sub-lethal
inocula of A. fumigatus increased the mortality caused by subsequent P. aeruginosa
infection. Co-infection of human bronchial epithelial cells (CFBE41o−) with both
pathogens did not enhance IL-6 and IL-8 production beyond the levels observed
following single infections. In addition, both pathogens stimulated cytokine secretion via
the same two mitogen-activated protein kinases (MAPKs) signaling pathways, ERK and
p38. Mixed species biofilms showed overall reduced biofilm development with crystal
violet staining. Quantification by species-specific qPCR revealed that both pathogens
had mutually antagonistic effects on each other. A. fumigatus supernatants showed
strong anti-Pseudomonal activity and gliotoxin was the main active agent. Gliotoxin
resulted in varying levels of anti-biofilm activity toward other bacteria commonly found in
the CF airways. Gliotoxin produced by A. fumigatus colonizing the CF airways may have
a significant impact on the CF airway microbiome composition with potential clinical
implications.
Keywords: co-colonization, cystic fibrosis, Aspergillus fumigatus, Pseudomonas aeruginosa, biofilm,
inflammation, gliotoxin
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INTRODUCTION
Cystic fibrosis (CF) is the most common inherited life-shortening
condition, characterized by mutations in the CF transmembrane
conductance regulator (CFTR) gene. The resulting defective
chloride secretion, altered airway surface liquid and impaired
mucociliary secretion results in recurrent chronic respiratory
infections (Haq et al., 2016). CF airway disease is characterized
by a continuous cycle of persistent infection and inflammation
contributing to morbidity and mortality in CF. Early detection
and eradication of these infections remains a major challenge
in CF lung disease management. P. aeruginosa is the leading
cause of infection in patients with CF with approximately 28.4%
being colonized by 71 months (Douglas et al., 2009). Prevalence
in adults varies from 31 to 49.6% in recent reports (Salsgiver
et al., 2016; Reece et al., 2017). Early intervention is paramount
as P. aeruginosa is very difficult to eradicate once it has colonized
the airways. P. aeruginosa is independently linked to worsened
prognosis for CF patients; they have a decreased life expectancy
of 30 years, compared with 40 years in non-colonized patients,
experiencing a more rapid decline in pulmonary function with
more frequent hospitalizations (Kosorok et al., 2001; Li et al.,
2005). P. aeruginosa is a very accomplished bacterium and can
adapt to life in the CF airway (Friman et al., 2013; Cullen and
McClean, 2015).
Cystic fibrosis airway microbiology has recently been
revolutionized by the discovery of complex communities of
bacteria and fungi co-existing in the lungs of adults and children
with CF (Sibley et al., 2011; Delhaes et al., 2012). These studies
have highlighted a number of new and emerging microorganisms
in CF airway disease (Bittar et al., 2008; Spicuzza et al., 2009)
but have also verified the importance of common CF pathogens,
such as P. aeruginosa (Cox et al., 2010; Klepac-Ceraj et al., 2010;
Coburn et al., 2015) and Aspergillus fumigatus (Delhaes et al.,
2012). Perhaps most importantly these metagenomic studies
have confirmed that important CF pathogens do not colonize
the airways in isolation. Exacerbation and disease progression
in patients may be influenced by the interactions between
these microorganisms in the CF airway. P. aeruginosa was
identified in 54.1% of CF patients with persistent A. fumigatus
infection and these co-colonized patients showed decreased lung
function compared with patients clear of both pathogens (Amin
et al., 2010). Direct contact between these organisms or indirect
signaling may influence microbial pathogenicity (Duan et al.,
2003).
Several studies have shown that P. aeruginosa interacts with
other bacteria and fungi, inhibiting Burkholderia cenocepacia
(Costello et al., 2014), Candida albicans (Brand et al., 2008)
and Scedosporium aurantiacum (Kaur et al., 2015). P. aeruginosa
increases its virulence when in co-culture with Gram-positive
bacteria in Drosophila (Korgaonkar et al., 2013). P. aeruginosa
pathogenicity was enhanced in a rat lung infection model by the
presence of oropharyngeal flora and the increased virulence may
be due to interspecies communication via autoinducer-2 (AI-2)
mediated signaling (Duan et al., 2003). Both filamentation and
biofilm formation of A. fumigatus was inhibited by P. aeruginosa
through direct cell contact and by secreted molecules. Recently it
was demonstrated that P. aeruginosa and A. fumigatus interact
with each other via volatile communication mediators and
that stimulation of A. fumigatus growth by P. aeruginosa did
not require direct contact (Briard et al., 2016). P. aeruginosa
culture filtrates inhibited and damaged A. fumigatus biofilms via
metacaspase activation (Shirazi et al., 2016). P. aeruginosa elastase
production is enhanced in the presence of A. fumigatus and may
play a role in the damaging pathology associated with the CF lung
and may explain why, at least in part, co-colonized patients have
a poorer prognosis (Smith et al., 2015).
We have recently shown that 3.1% of Irish CF patients
registered with the CF registry of Ireland were intermittently
co-colonized with A. fumigatus and P. aeruginosa (Reece et al.,
2017). In addition, co-colonization with both pathogens (even
intermittently) resulted in comparable levels of hospitalizations,
respiratory exacerbations and lung function reduction as in
patients that were chronically colonized with P. aeruginosa alone
which emphasizes the clinical significance of co-colonization
with these microorganisms. The potential consequences of
co-colonization with these two pathogens on infection and
inflammation are poorly understood. We now report our
investigations on the interactions between A. fumigatus and
P. aeruginosa in terms of their virulence and the effect co-
colonization has on the CF host immune system.
MATERIALS AND METHODS
P. aeruginosa and A. fumigatus Strains
and Growth Conditions
A number of clinical isolates and reference strains were used
in this study and are listed in Table 1. All experiments
were performed in a SafeFAST Class II Biosafety cabinet
(Mason Technology, Dublin, Ireland), in compliance with BSL-
II containment. Two P. aeruginosa isolates (PAco1 and PAco2)
were isolated from the sputum of a CF patient co-colonized with
A. fumigatus (AFco1 and AFco2). Sputum was homogenized by
adding Sputasol 1:1 (Thermo Fisher Scientific) and incubated
at 35◦C for 15–20 min shaking. A volume of 50 µl was
plated on CHROMAgar Pseudomonas (CHROMAgarTM) (LIP
Diagnostics, Galway, Ireland) and incubated at 35◦C for 48 h.
Any blue/green colonies were picked and identity confirmed
using Mass Spectrometry (Biomerieux Vitek). The AFref1, 1gliG
and complement1gliGc strains were previously described (Davis
et al., 2011). A. fumigatus strains were routinely cultured on Malt
Extract agar (MEA) plates (LIP Diagnostics, Galway, Ireland) for
48 h at 37◦C and conidia were harvested using phosphate buffer
saline (PBS) (Sigma, Wicklow, Ireland) containing 0.1% Tween
80 (PBST) (Sigma, Wicklow, Ireland). Conidia were enumerated
on a Fast Read 102 counting slide (Biosigma, Cona, Italy). Liquid
cultures were grown in Malt extract broth and sterile filtered
through a 0.22 µM Whatman filter (Sigma, Wicklow, Ireland)
to harvest culture supernatants (CSNs). A. fumigatus CSNs were
plated on MEA and cultured overnight to confirm the absence
of conidia. All P. aeruginosa isolates were grown on Blood
agar plates (LIP Diagnostics) and cultured in Luria-Bertani (LB)
(Sigma, Wicklow, Ireland) broth at 37◦C. Overnight cultures in
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TABLE 1 | Strains used in this study.
Strain name Source Strain type Reference
PAref1 ATCC Reference ATCC 27853
PA27 CF patient Mucoid IST 27 De Soyza et al., 2013
PA27N CF patient Non-mucoid IST 27N De Soyza et al., 2013
PAco1 CF patient Co-colonizer This study
PAco2 CF patient Co-colonizer This study
AFref1 ATCC Reference ATCC Af293
AFref2 ATCC Reference ATCC 26933
AF1 CF patient Clinical This study
AF2 CF patient Clinical This study
AFco1 CF patient Co-colonizer This study
AFco2 CF patient Co-colonizer This study
1gliG ATCC Mutant Davis et al., 2011
1gliGc ATCC Complement Davis et al., 2011
Stenotrophomonas
maltophilia
ATCC Reference ATCC 17666
S. aureus ATCC Reference ATCC 25923
Haemophilus
influenzae
NCTC Reference 8468
A. baumannii Patient Clinical This study
B. multivorans BCCM/LMG Clinical LMG 13010
LB broth were diluted to obtain an OD600nm of 0.6 and sterile
filtered through a 0.22 µM Whatman filter (Sigma, Wicklow,
Ireland) to harvest CSNs. P. aeruginosa CSNs were plated on
blood agar and cultured overnight to confirm absence of bacterial
cells.
Virulence of Co-colonizing Pathogens in
the Galleria mellonella Acute Infection
Model
In order to establish bioburden to be injected, 10-fold serial
dilutions of A. fumigatus strains were prepared in PBS and
conidia counted on MEA plates. P. aeruginosa strains were
cultured in LB broth for 24 h at 37◦C, diluted to OD600nm 0.6,
pelleted and resuspended and 10-fold serial dilutions prepared of
the neat sample (2 × 107 CFU/ml) in 10 mM MgSO4 (Sigma,
Wicklow, Ireland) and 50 µl aliquots spread on blood agar
to confirm the bioburden. Prior to co-infection studies, kill
curves (CFU/ml versus larval survival) for each P. aeruginosa or
A. fumigatus strain were established by injecting serial dilutions
of each P. aeruginosa or A. fumigatus strain into individual
groups of larvae. The LD50 (CFU that resulted in 50% larval
death after 24 h) of each strain was determined. For co-infection
studies, groups of six healthy G. mellonella larvae (Livefoods
Direct, Sheffield, United Kingdom) in the final instar larval
stage weighing 0.25–0.35 g were selected and 10 µl of serial
dilutions were injected into the hind left pro-leg using a 29-gauge
needle (BD Biosciences, Oxford, United Kingdom) as described
by Cullen et al. (2015). To establish the effect of P. aeruginosa
infection in an A. fumigatus colonized model, G. mellonella were
inoculated with non-lethal doses of A. fumigatus strains at 102
conidia/10 µl (Supplementary Figure 2) 24 h prior to subsequent
inoculation with P. aeruginosa strains at a concentration of
2 × 105 CFU/10 µl. For experiments that required a second
injection the hind right pro-leg was used. In all experiments
two control groups were used, a group with no manipulation
and a vehicle control group. Larvae were incubated at 37◦C for
the duration of each experiment and assessed every 24 h up to
7 days for viability as determined by their response to touch. The
LD50 dose was determined from the percentage survival in three
independent experiments.
Culture of Bronchial Epithelial Cell Lines
CFBE41o− bronchial epithelial cells (CFBEs) (Gruenert et al.,
1988) were cultured in T-75 flasks coated with 1% (v/v)
fibronectin, 1% (v/v) collagen, and 10% (v/v) bovine serum
albumin with minimum essential media (MEM) supplemented
with 10% fetal bovine serum (FBS), 1% (v/v) L-glutamine,
1% (v/v) non-essential amino acids and 1% (v/v) penicillin-
streptomycin at 37◦C in 5% CO2. Culture media was replenished
every 2 days and the cells were sub-cultured by trypsin digestion
when growth had reached 80–90% confluence. All culture
reagents were supplied by Sigma (Wicklow, Ireland).
Infection of CFBE Cells With
P. aeruginosa and A. fumigatus
CFBE41o− bronchial epithelial cells were seeded (4 × 105
cells/ml) onto coated 24-well plates and incubated for 24 h at
37◦C in 5% CO2 overnight. The media was changed to serum
free media and the cells incubated for a further 24 h. Overnight
cultures of P. aeruginosa were inoculated into 100 ml of LB
broth and incubated at 37◦C until OD600nm 0.6 was reached. The
CFU/ml was determined by plating on blood agar. The cultures
were centrifuged at 4,500 × g for 10 min, resuspended in 1 ml
MEM and applied to CFBE cells at 2× 107 CFU/ml [multiplicity
of infection (MOI) of 50:1] in triplicate and incubated at 37◦C
with 5% CO2 (Costello et al., 2014). A. fumigatus cultures
centrifuged at 4,500 × g for 10 min were resuspended in 1 ml
MEM and conidia applied to CFBE cells at a concentration
of 8 × 105 conidia/ml (MOI of 2:1) in triplicate. The effect
of P. aeruginosa and A. fumigatus infection on the viability of
CFBE cells was assessed by the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide MTT Cell Proliferation Assay Kit
(Cayman Chemical, Ann Arbor, MI, United States) according
to the manufacturer’s instructions. The CFBE cells infected with
P. aeruginosa PAref1 (MOI of 30:1, 50:1, 80:1, and 100:1) or
A. fumigatus AFref1 (MOI of 1:1, 2:1, 5:1, 10:1) in triplicate for
24 h at 37◦C in 5% CO2. Control cells were incubated with MEM
only.
CFBE41o− bronchial epithelial cells were co-infected with
P. aeruginosa and A. fumigatus in the presence MAPK inhibitors
as follows: 10 µM of SP600125 (JNK inhibitor), SB203580
(p38 inhibitor) or PD 98,059 (ERK inhibitor) (Sigma, Wicklow,
Ireland) or combinations of these for 1 h at 37◦C. The cells were
subsequently infected with P. aeruginosa strains (MOI of 50:1) or
A. fumigatus stains (MOI of 2:1) in triplicate. After 24 h infection
the plates were centrifuged and the supernatant removed and
stored at −80◦C for the pro-inflammatory response assays.
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Experiments were carried out in triplicate on three independent
occasions.
Measurement of IL-6 and IL-8 in Cell
Supernatants by Enzyme-Linked
Immunosorbent Assay (ELISA)
IL-6 and IL-8 were measured by sandwich ELISA (BD
Biosciences, Oxford, United Kingdom) according to
manufacturer’s instructions. Briefly, the wells were coated with
100 µl/well of anti-human IL-6 or IL-8 monoclonal antibody
and blocked for 1 h at room temperature with 200 µl/well assay
diluent (PBS with 10% FBS). Standards (100 µl/well recombinant
human IL-6 or IL-8) were prepared at a concentration range of
0–300 pg/ml for IL-6 and 0–200 pg/ml for IL-8 and plates were
incubated for 2 h at room temperature. The detection antibody
and Streptavidin-HRP reagent were added and incubated for a
further 1 h at room temperature. The plates were washed with
PBS with 0.05% Tween-20 (wash buffer) seven times, before
addition of TMB substrate and incubation for 30 min in the
dark. The stop solution (1M H3PO4) at 50 µl/well was added
and the absorbance was read at 450 nm using Gen 5 plate reader
(Bio-Tek). Experiments were carried out in triplicate on three
independent occasions.
Examination of Well Diffusion With
P. aeruginosa and A. fumigatus
Well diffusion assays were performed on MEA plates with 4× 105
CFU/100 µl lawns of P. aeruginosa and 4 × 105 CFU/100 µl
A. fumigatus inoculated in the wells and vice versa. The zones of
inhibition were examined after 48 h incubation at 37◦C.
Determination of Biofilm Formation
Using the Crystal Violet Assay
In vitro biofilm formation was measured in round bottom
plastic 96-well plates using crystal violet to measure the biomass
using a modification of a previously described method (O’Toole
and Kolter, 1998). Briefly, P. aeruginosa and A. fumigatus
cells/conidia were seeded into a 96-well plate at 1 × 106 CFU/ml
per well. Plates were incubated at 37◦C for 48 h. The effect of
A. fumigatus conidia on P. aeruginosa biofilm formation was
determined by adding A. fumigatus conidia to P. aeruginosa
biofilms at time zero. The biomass of the mixed biofilm was then
compared to the biomass of the sum of the P. aeruginosa and
A. fumigatus untreated biofilm controls. P. aeruginosa cells were
also seeded with 72 h CSNs from A. fumigatus. Sterile LB media
was used in negative controls. Fresh media was added to the wells
every 24 h to replenish nutrients. Unattached bacterial/fungal
cells were removed by rinsing with 250 µl of distilled water
five times. The wells were air dried for 45 min. The adherent
cells were stained with 1% (w/v) Crystal Violet (Sigma, Wicklow,
Ireland) at room temperature for 30 min and wells washed again.
The dye was solubilized with 95% ethanol containing 0.05% (l/v)
Triton X-100 (Sigma, Wicklow, Ireland). Biofilm formation was
determined by reading the absorbance at 590 nm (Synergy H1
Multi-Mode Reader, Bio-Tek). Each experiment was carried out
on three independent occasions, with six strain replicates per 96
well plate.
Dual Quantification of Species-Specific
Biofilm Growth by qPCR
Pseudomonas aeruginosa strains and A. fumigatus strains were
each seeded at 1× 106 CFU/ml in a 6-well round bottom plate for
0, 24, 48, and 72 h. Co-cultured biofilms were created by seeding
wells with 1 × 106 CFU/ml of an A. fumigatus strain together
with 1 × 106 CFU/ml of a P. aeruginosa strain. P. aeruginosa
biofilms were also seeded with 24, 48, and 72 h A. fumigatus
CSNs. Wells containing sterile LB media were used as negative
controls. The plates were incubated at 37◦C and spent LB broth
replenished every 24 h. At 24, 48, and 72 h the broth was aspirated
and the biofilms removed by scraping and transferred to a fresh
tube. All biofilm experiments were performed in triplicate on
three independent occasions. The biofilms were vortexed and
50 µM propidium monoazide (PMA) (Biotium, Fremont, CA,
United States) was added prior to incubation in the dark for
30 min. The samples were irradiated with light at 464–476 nm
using the phAST Blue activation system (GenUIL, Barcelona,
Spain) for 15 min to activate the PMA and exclude DNA from
non-viable cells (Nocker et al., 2006). The samples were then
centrifuged at 5,000 × g for 10 min and pellets resuspended in
500 µl PBS before centrifuging again at 5,000× g for 10 min.
Pelleted cells were resuspended in 200 µl molecular grade
water (Sigma, Wicklow, Ireland) before transferring to sterile
screw-capped tube containing 0.3 g sterile acid washed glass
beads (Sigma, Wicklow, Ireland) and vortexing in a horizontal
multi-vortexer for 180 s at 2500 rpm. The tubes were centrifuged
at 420 × g for 1 min, supernatants transferred to fresh
centrifuge tube and the DNA eluted using the High Pure PCR
Template Preparation kit (Roche, Clare, Ireland) according to the
manufacturer’s instructions. A negative extraction control was
performed for each batch of DNA extractions where the entire
DNA extraction protocol was performed on 200 µl molecular
grade water.
Pseudomonas aeruginosa was specifically quantified by
multiplex qPCR with primers for the ecfX and gyrB genes and
hydrolysis probes ecfX-TM and gyrB-TM (Qin et al., 2003;
Anuj et al., 2009). A. fumigatus was quantified using primers
and probed for the internal transcribed spacer 1 (ITS1) region
(Walsh et al., 2011) (Supplementary Table 1) All primers
and probes were supplied by Eurofins Genomics, Ebersberg,
Germany. The master mix was composed of 10 µl of TaqMan
Gene Expression (Biosciences, Dublin, Ireland), 0.4 µM of each
primer, 0.16 µM of each hydrolysis probe, and 4 µl of DNA
in a final reaction volume of 20 µl. Cycling was performed on
QuantStudioTM 5 Real Time PCR System (Applied Biosystems,
Dublin, Ireland), with an initial hold at 95◦C for 15 min,
followed by 45 cycles at 95◦C for 15 s, and 60◦C for 1 min, with
a CT of 35 being the threshold. A negative control consisting
of master mix without DNA was included in each qPCR run
alongside the negative extraction control. DNA extracted from
10-fold serial dilutions (101–106 CFU/ml) of either AFref1 or
PAref1 was used to generate a standard curve and to act as
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a positive control. The standard curves of different reference
concentrations were plotted against the corresponding CT values
and used to determine the concentrations of unknown samples.
A ctrA plasmid was amplified in duplicate on each qPCR run
(Supplementary Table 1) as a reaction control. Each sample
was run in duplicate and samples were considered as positive if
both duplicates showed CT values below 35. The amplification
efficiency of the qPCR was calculated from the slope of the
standard curve using the following equation; E = 10 (−1/slope).
Bacterial Biofilms Treated With Gliotoxin
Pseudomonas aeruginosa, Staphylococcus aureus,
Stenotrophomonas maltophilia, B. cenocepacia, Acinetobacter
baumannii, H. influenzae, and Escherichia coli were seeded at
1 × 106 CFU/ml per well in a 96 well plate and a range of
concentrations of gliotoxin (Gt) (0.2–1 µM) were added to each
well and incubated at 37◦C for 48 h. HPLC analysis showed the
concentration of gliotoxin produced by A. fumigatus at 72 h
equates to approximately 0.8 µM commercial Gt (Coughlan
et al., 2012), which was therefore used in this study. Fresh media
was added to the wells every 24 h to replenish nutrients. Crystal
violet assays were carried out to determine if Gt reduced the
biomass of the biofilms of each of these pathogens.
Data Analysis
Two-way ANOVAs with Bonferroni multiple comparisons tests
were used to analyze the cytokine and MAPK assays. One-way
ANOVAs with Dunnett’s multiple comparisons tests were used
to analyze the crystal violet, the MTT and qPCR assays. LD50
values were compared via Student t-tests to determine statistical
significance. P-values < 0.05 were considered significant. All
results were analyzed using GraphPad Prism 6 and 7. The qPCR
data was analyzed using the Quantstudio Design and Analysis
software (Applied Biosystems).
RESULTS
Pre-exposure of G. mellonella to a
Non-lethal Dose of A. fumigatus
Significantly Increased Larvae Mortality
due to P. aeruginosa in a
Strain-Dependent Manner
As an initial visual evaluation of the potential for the two
pathogens to interact with each other, we evaluated inhibition
of growth in well diffusion assays. PA27 and PA27N inhibited
A. fumigatus strains with zone of inhibition (ZOI) apparent
around the wells (Supplementary Figures 1A–D). The two clinical
P. aeruginosa strains (PAco1 and PAco2) which were isolated
from patients co-colonized with A. fumigatus also caused ZOIs
in the growth of their respective co-colonizing strains AFco1 and
AFco2 (Supplementary Figures 1E,F).
In order to examine whether these two pathogens alter their
virulence when co-infecting with the other, their virulence in
the G. mellonella acute infection model was evaluated. A non-
lethal dose for A. fumigatus was first determined. All A. fumigatus
strains caused larval mortality in a dose dependent fashion
(Supplementary Figure 2) and day 4 was identified as the optimal
time-point for distinguishing subtle differences between strains.
There was 100% survival of the G. mellonella after 3 days
when injected with 102 conidia/ml for all A. fumigatus strains.
Therefore, 102 conidia/ml of A. fumigatus were considered a
non-lethal dose after 3 days in future experiments.
P. aeruginosa reference strain PAref, showed an LD50 of
1 CFU/ml. Pre-exposure of larvae to a non-lethal dose of
A. fumigatus strain AF1 significantly reduced the LD50 of
P. aeruginosa PAref (p = 0.012) compared to PAref alone
indicating an apparent increase in virulence of PAref (Figure 1A).
Consistent with this, the LD50s of the PAco1 strain was also
reduced in the presence of AFref (p = 0.007) and AF1 (p = 0.003)
(Figure 1B). The mucoid P. aeruginosa strain, PA27, showed
a much higher LD50 than its non-mucoid conversion isolate
and pre-exposure of larvae to all but one A. fumigatus strain
significantly reduced LD50s of P. aeruginosa (p = 0.0002 for all
three comparisons) compared to PA27 alone (Figure 1C). The
LD50s of the non-mucoid P. aeruginosa strain, PA27N, reduced
in the presence of AFref (p = 0.0018), AFco1 (p = 0.0082),
AF1 (p = 0.001) and AF2 (p = 0.008) (Figure 1D). Interestingly
pre-exposure to the co-colonizing strain, AFco1 did not reduce
the LD50 of PA27, PAref or PAco1 (Figures 1A–C). Overall
pre-exposure of larvae to a non-lethal dose of the majority of
A. fumigatus isolates resulted in an apparent increase in virulence
of the individual P. aeruginosa isolates when co-infecting in
G. mellonella and this increase seems to be strain specific.
P. aeruginosa and A. fumigatus
Co-infection Altered the
Pro-inflammatory Response in CF
Epithelial Cells
Given that both P. aeruginosa and A. fumigatus elicit a profound
pro-inflammatory response at the lung epithelium, we wanted
to examine the effects of co-colonization on the inflammatory
response of CFBE cells relative to A. fumigatus or P. aeruginosa
isolates alone. Only two combinations resulted in significantly
increased IL-6 and IL-8 secretion (Figure 2). There was a
significant increase in IL-6 production from CFBE cells when
infected with co-cultures of PA27 and AFco1 compared to PA27
or AFco1 alone (p ≤ 0.0001 and p ≤ 0.0001, respectively)
(Figure 2B). An increase in IL-8 release was also observed when
CFBE cells were co-infected with PA27N and AFco1 compared
to PA27N (p = 0.013) or AFco1 alone (p < 0.0001) (Figure 2F).
In contrast, IL-6 and IL-8 production from CFBE cells when
infected with all other co-cultures showed the cytokine released
did not increase compared to either P. aeruginosa or A. fumigatus
alone (Figures 2A,C–E). The lack of enhancement of pro-
inflammatory responses for the majority of tested co-infections
suggests that co-infections of A. fumigatus and P. aeruginosa
may not generally further exacerbate the inflammatory response.
Uninfected controls produced on average of 74 pg/ml IL-6 and
53 pg/ml IL-8. The CFU of P. aeruginosa and A. fumigatus used
to infect CFBE cells (MOI 50:1 and 2:1, respectively) were not
cytotoxic to the CFBE cells (Supplementary Figure 3) ensuring
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FIGURE 1 | Virulence of P. aeruginosa and A. fumigatus co-infections in the G. mellonella infection model. LD50 of P. aeruginosa (A) PAref, (B) PAco1, (C) PA27, and
(D) PA27N following pre-exposure to non-lethal doses of A. fumigatus strains in the G. mellonella infection model. Experiments were carried out on three
independent occasions and error bars represent standard error. ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001.
that the lack of enhancement of cytokine release was not due to a
loss in viability of the CFBE cells.
P. aeruginosa and A. fumigatus Signaled
via the Same MAPK Pathway
In order to further investigate why the majority of co-infections
did not have an additive effect on the secretion of IL-6 and IL-
8, we examined the signaling mechanisms of both pathogens. All
four co-cultures elicited reduced IL-6 secretion in the presence of
either ERK or p38 inhibitors and these levels were further reduced
to that of the uninhibited controls when ERK and p38 inhibitors
were used in combination (p ≤ 0.0001 in all four co-cultures).
These reductions in IL-6 secretion varied from 16 to 26% relative
to the corresponding uninhibited samples, suggesting the co-
culture of both P. aeruginosa and A. fumigatus induce an IL-6
response via the ERK and p38 MAPK pathways (Supplementary
Figures 4A–D).
In all co-culture combinations there was also a significant
decrease in IL-8 secretion in the presence of the combination
of ERK and p38 inhibitors. The IL-8 secretion was reduced to
11–19% (p ≤ 0.0001) of the uninhibited samples which suggests
that the IL-8 secretion elicited by the co-cultures of P. aeruginosa
and A. fumigatus also signals via the ERK and p38 pathways
(Supplementary Figures 4E–H). When the CFBEs were infected
with the co-cultures PA27 and AF1 in the presence of JNK
inhibitors there was only a slight decrease in IL-8 production to
89% (p = 0.04) (Supplementary Figure 4E). Overall the impact of
the JNK pathway was minimal.
A. fumigatus and P. aeruginosa Grown in
Co-cultured Biofilms Displayed Mutually
Antagonistic Behavior
Initial well diffusion assays suggested that there was a degree
of antagonism between the two pathogens, but this was not
quantifiable. In order to quantitate the overall level of antagonism
mixed biofilms of A. fumigatus conidia and P. aeruginosa cells
were prepared. It was apparent the resulting biofilm biomass
(as measured by crystal violet) was significantly reduced to 60–
79% relative to the sum of single species biofilm controls for
all isolates tested (range p = 0.0001–0.011) (Table 2). These
results suggest that when P. aeruginosa and A. fumigatus were
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FIGURE 2 | IL-6 and IL-8 secretion from CFBE cells in response to co-infection of P. aeruginosa cells and A. fumigatus conidia. Secretion of IL-6 pg/ml (A–C) and
IL-8 pg/ml (D–F) from CFBE cells in response to co-infections of P. aeruginosa cells PAco1 (A,D), PA27 (B,E), PA27N (C,F) and A. fumigatus conidia. Black bars
represent P. aeruginosa alone, light gray bars A. fumigatus alone and dark gray bars co-exposure of the CFBEs. Experiments were carried out on three independent
occasions in triplicate and error bars represent standard deviation. ∗p ≤ 0.05, ∗∗∗∗p ≤ 0.0001.
cultured together in a co-cultured biofilm, biofilm formation
was significantly impaired relative to that formed by individual
species. Overall mixed biofilms between any of the P. aeruginosa
strains and any of the A. fumigatus strains showed reduced
total biofilm formation, compared with the individual biofilm on
its own.
In order to quantify the inhibitory effects at the species level,
species-specific qPCR was carried out to determine the reduction
of A. fumigatus biofilms by P. aeruginosa and vice versa in the
mixed biofilms. Optimization of qPCR resulted in amplification
efficiencies of P. aeruginosa and A. fumigatus of 105.3% (+4.97%
and ranged between 90.6 and 112.2% efficiency). The R2 values
of the standard curves varied from 0.9807 to 0.9985 and all
duplicates were within 0.5 Ct values of each other, indicating high
consistency across replicates.
Aspergillus fumigatus-specific qPCR confirmed that
A. fumigatus AFref1 biofilm increased over time from seeding
at 0 to 72 h culminating in an estimated 3.8 × 108 equivalent
conidia/ml. In the mixed biofilm PAref did not cause any
reduction in AFref1 biomass up to 48 h, however, at 72 h
A. fumigatus was significantly reduced in the co-cultured biofilm
from 3.8 × 108 equivalent conidia/ml to 3.9 × 104 CFU/ml
(p ≤ 0.0001) (Figure 3A), demonstrating that the presence of
P. aeruginosa in a co-cultured biofilm with A. fumigatus inhibited
the viable fungal biofilm.
The biofilm formed by P. aeruginosa reference strain PAref in
isolation increased over 72 h culminating in 7.5× 108 equivalent
CFU/ml. P. aeruginosa biofilm formation was significantly
reduced when in a mixed biofilm with AFref1 at 48 h by over
2 log (p ≤ 0.0001) and at 72 h (p ≤ 0.0001) (Figure 3A),
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TABLE 2 | Reduction in mixed species biofilm formation in comparison to single
species biofilms as measured by the crystal violet assay.
Inhibition in biofilm formation (%) ± standard deviation∗
PA27 PA27N PAco1 PAco2 PAref
AFref1 71.8 ± 2.6 68.4 ± 3.4 66.3 ± 0.6 64.2 ± 4.2 60.5 ± 6
AF1 77.4 ± 4 74.2 ± 3.3 73.5 ± 1.5 72.8 ± 1.3 66.4 ± 3.6
AF2 79.1 ± 3.3 69.4 ± 1.3 74.6 ± 1.1 68.2 ± 4.4 62.5 ± 6
AFco1 74.2 ± 7.7 68 ± 4.1 62.3 ± 5.3 70.2 ± 2.7 67.1 ± 5.2
AFco2 77.8 ± 1.3 68.6 ± 2.4 66.2 ± 4.4 63.3 ± 2.2 62.9 ± 4.4
∗P ≤ 0.03. The % inhibition was determined from the difference between the OD
value of each mixed biofilm and the sum of the OD values of biofilm formed by the
corresponding individual species.
demonstrating that the presence of A. fumigatus in a co-
cultured biofilm with P. aeruginosa inhibited the viable bacterial
biofilm.
Similar results were observed with mixed biofilms of the co-
colonizing clinical strains. A. fumigatus AFco1 biofilm formation
increased over 72 h culminating in an estimated 7.6 × 108
equivalent conidia/ml. At 72 h A. fumigatus was significantly
lower in the co-cultured biofilm at 6.8 × 105 equivalent
conidia/ml (p ≤ 0.0001) (Figure 3B). The biofilm of PAco1
increased over time culminating in 5.4× 108 equivalent CFU/ml
at 72 h. P. aeruginosa biofilm formation was significantly less
when in a mixed biofilm with AFref1 at 72 h at 8 × 105
equivalent CFU/ml (p = 0.0024) (Figure 3B). A. fumigatus
AFco2 biofilm increased over 72 h culminating in an estimated
6.1 × 108 equivalent conidia/ml. In the mixed biofilm AFco2
was significantly reduced when in a mixed biofilm with PAco2
at 48 h and at 72 h (p = 0.0085, Figure 3C). The biofilm of
PAco1 increased over time culminating in 5.9 × 108 equivalent
CFU/ml at 72 h. P. aeruginosa biofilm formation was significantly
reduced when in a mixed biofilm with AFref1 at 72 h to
8.2 × 105 equivalent CFU/ml (p ≤ 0.0001) (Figure 3C). It is
apparent that there is a strong mutual antagonistic relationship
present between A. fumigatus and P. aeruginosa in a mixed
biofilm.
A. fumigatus CSNs Inhibited
P. aeruginosa Biofilms
Pseudomonas aeruginosa biofilms were treated with 72 h CSNs
from A. fumigatus and the biomass measured by crystal violet.
The bacterial biomass was reduced to 72–88% of the untreated
biofilm controls (Table 3), indicating that A. fumigatus CSN can
significantly decrease bacterial biofilm growth.
In order to quantify the reduction of P. aeruginosa
biofilm formation by A. fumigatus CSN, qPCR was utilized
and the bacterial cells were treated with 24, 48, and 72-h-
old A. fumigatus CSN and grown for 48 h. When PAco1
biofilms (1.01 × 109 CFU/ml) were treated with 24-h-
old AFco1 CSN there was no biofilm decrease, however,
when the bacterial biofilm was exposed to 48 h and 72 h
AFco1 CSN the viable P. aeruginosa biofilm decreased to
8.6 × 105 CFU/ml (p = 0.0183), and 1.9 × 106 CFU/ml
FIGURE 3 | Reduction of A. fumigatus and P. aeruginosa biofilm when in
mixed species biofilms. Quantification of biofilm biomass as measured by
qPCR of A. fumigatus biofilm alone (open squares) and when in a co-cultured
biofilm with P. aeruginosa (open circles) or P. aeruginosa biofilm alone (inverted
triangles) and when in a co-cultured biofilm with A. fumigatus (upright
triangles). (A) AFref1 and PAref individually and in co-cultured biofilm;
(B) AFco1 and PAco1 individually and in co-cultured biofilm; (C) AFco2 and
PAco2 individually and in co-cultured biofilm. Experiments were carried out on
three independent occasions and error bars represent standard error.
∗∗p ≤ 0.01, ∗∗∗∗p ≤ 0.0001.
(p = 0.0184), respectively. Figure 4A, suggesting 48-h and 72-
h-old AFco1 CSNs inhibited the growth of P. aeruginosa viable
biofilms.
When PAco2 biofilms were treated with 24-h-old AFco2 CSN
the biofilm decreased from 1.1 × 109 CFU/ml to 8.5 × 108
CFU/ml (p = 0.028) and when the bacterial biofilm was
exposed to 48 h and 72 h AFco2 CSN the viable biofilm
decreased to 6.7 × 105 CFU/ml (p = 0.001) and 2.2 × 106
CFU/ml (p = 0.001), respectively (Figure 4B), suggesting CSN
from A. fumigatus inhibited growth of P. aeruginosa viable
biofilms. PAref biofilms decreased from 7.55 × 108 CFU/ml
to 1.1 × 107 CFU/ml and 2.1 × 106 CFU/ml (p = 0.0012
and p = 0.0011, respectively) when treated with 48 h and
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TABLE 3 | Reduction of P. aeruginosa biofilm formation when treated with 72 h CSNs from A. fumigatus.
Inhibition in biofilm formation (%) ± standard deviation∗
AFref1 AF1 AF2 AFco1 AFco2
PA27 77.2# ± 12.5 77.6 ± 9.8 72.8# ± 6.1 84.1# ± 22.7 74.2 ± 13.8
PA27N 80.0 ± 4.8 83.6 ± 8.4 76.8 ± 2.5 79.3 ± 4.2 74.9 ± 4.8
PAco1 81.0# ± 1.4 73.6 ± 9.6 78.7 ± 4.6 75.2 ± 3 80.0 ± 12.8
PAco2 85.4# ± 14.1 83.2# ± 12.2 86.4# ± 12 85.8# ± 26 88.3# ± 22.9
PAref1 81.8 ± 3.2 77.6 ± 2.5 75.8 ± 2.4 77.1 ± 1.7 76.5 ± 10.4
∗P ≤ 0.03, #not significant. Results are presented as the % that the biofilms were reduced to in the presence of CSN relative to control untreated biofilms.
FIGURE 4 | Reduction of P. aeruginosa biofilm when exposed to A. fumigatus CSN. Quantification of 48 h P. aeruginosa (A) PAco1, (B) PAco2, (C) PAref1 biofilms
when exposed to (A) AFco1 (B) AFco2 (C) AFref1, AFref1 1GliG and AFref1 1GliGc 24, 48, and 72-h-old CSNs as determined by qPCR. Experiments were carried
out on three independent occasions and error bars represent standard deviation. ∗p ≤ 0.05, ∗∗p ≤ 0.01, ∗∗∗p ≤ 0.001, ∗∗∗∗p ≤ 0.0001.
72 h AFref1 CSNs (Figure 4C) suggesting 48-h and 72-
h-old AFref1 CSNs inhibited growth P. aeruginosa viable
biofilms.
Gliotoxin Produced by A. fumigatus
Inhibited P. aeruginosa Biofilm Formation
Gt is known to be produced by A. fumigatus in high
quantities in 48 h and 72 h CSNs but in relatively low
concentration at 24 h (Reeves et al., 2004) leading us to
investigate whether Gt was causing this anti-Pseudomonal and
anti-biofilm effect. P. aeruginosa cells were treated with CSNs
from the 1gliG mutant AFref1 strain and viable P. aeruginosa
biofilms were quantified by qPCR after 48 h. The CSNs
from the 1gliG mutant strain did not inhibit P. aeruginosa
biofilm formation suggesting Gt is the main inhibitory agent
secreted at 48 h and 72 h by A. fumigatus and has anti-
pseudomonal and anti-biofilm effects. Exposure to CSN from
the complemented strain AFref11gliGc strain restored inhibition
(Figure 4C).
Gliotoxin Inhibited Bacterial Biomass
In order to examine whether the gliotoxin inhibitory action was
specific to P. aeruginosa or it had general anti-biofilm effect, a
number of bacterial biofilms that are commonly found in the
CF airways were treated with Gt at concentrations of 0.2–1 µM
for 48 h. P. aeruginosa biofilms decreased significantly when
treated with Gt at concentrations of 1–0.4 µM (p = 0.0001–
0.0002) (Figure 5A). The biomass of S. maltophilia decreased
significantly when treated with Gt at concentrations of 1–0.4 µM
(p = 0.0012–0.0046) (Figure 5B). Gt also significantly decreased
the biofilms of S. aureus (p = 0.024), H. influenzae (p = 0.0015–
0.0146), A. baumannii (p = 0.0218–0.0426) and B. multivorans
(p = 0.0003–0.0403) (Figures 5C–F). These results indicate
gliotoxin has broad-spectrum antibacterial activity.
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FIGURE 5 | Reduction of bacterial biofilm formation when treated with gliotoxin. Percentage reduction of (A) PA: P. aeruginosa, (B) SM: S. maltophilia, (C) SA:
S. aureus, (D) HI: H. influenzae, (E) AB: A. baumannii, (F) BM: B. multivorans biofilms when treated with gliotoxin (Gt) at concentrations of 0.2–1 µM measured by
crystal violet assay. Experiments were carried out on three independent occasions and error bars represent standard deviation. ∗p ≤ 0.05, ∗∗p ≤ 0.01,
∗∗∗p ≤ 0.001, ∗∗∗∗p ≤ 0.0001.
DISCUSSION
The airways of patients with CF lung diseases host a diverse
and complex community of microorganisms (Beck et al., 2012;
Renwick et al., 2014). Inter-, intra-species and cross-kingdom
competition and/or cooperation within the airway microbiome
is likely to influence disease progression (Sibley et al., 2009;
Drescher et al., 2014). P. aeruginosa and A. fumigatus are isolated
together from the sputum of CF patients and it has been well
established that P. aeruginosa inhibits A. fumigatus in vitro (Kerr
et al., 1999; Mowat et al., 2010; Ferreira et al., 2015; Shirazi et al.,
2016; Anand et al., 2017) In contrast, much less is known about
the impact of A. fumigatus on P. aeruginosa. We now report
that P. aeruginosa and A. fumigatus have a mutually antagonistic
relationship both in planktonic and biofilm growth forms and
provide evidence that this may contribute to increased mortality
in the G. mellonella infection model and reduced inflammation
in CFBE epithelial cells. In particular, we report for the first time
the anti-pseudomonal and anti-biofilm effects of A. fumigatus on
P. aeruginosa.
We studied a combination of eleven clinical isolates and
reference strains, including co-colonizing clinical strains AFco1,
AFco2 with their respective co-colonizers, PAco1 and PAco2 as it
is widely accepted that different strains of the same species can
be phenotypically quite different. For instance, there is a broad-
strain dependent variation of the immune response elicited to
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A. fumigatus infection indicating that different isolates have
diverse virulence (Rizzetto et al., 2013). P. aeruginosa mucoid
conversion isolates also behave very differently (Ryall et al.,
2014). The mucoid phenotype showed enhanced microcolony
formation and tobramycin resistance compared to the non-
mucoid form of P. aeruginosa (Hentzer et al., 2001). We now
show that all of the strains caused varying degrees of antagonism,
virulence, and inflammation and demonstrate the strain-specific
interactions between organisms in microbial communities. It is
vital for studies of this nature to include a variety of clinical
strains with reference strains in order to get a thorough picture
of the nature of species interaction.
The well-diffusion assay, although relatively basic, provided
a good starting point for testing relationships between
microorganisms and showed that all the P. aeruginosa strains
tested inhibited the A. fumigatus strains, with zones of clearance
apparent around all wells. Antagonism is defined as the action
of any organism that suppresses or interferes with the normal
growth and activity of another organism. Antagonism was
evident in biofilm growth patterns where different strain
combinations caused varying degrees of disruption to overall
biofilm biomass generation. The crystal violet biofilm stain
is widely published as a measure of total biomass (O’Toole
and Kolter, 1998); however, when studying polymicrobial
biofilms, tracking growth of each species individually is essential.
We performed species-specific qPCR to distinguish between
A. fumigatus and P. aeruginosa in co-cultured biofilms and
found that both A. fumigatus and P. aeruginosa were negatively
impacted by the interaction revealing a mutually antagonistic
relationship. We have confirmed this across a range of reference
strains and clinical isolates. It is worth highlighting that this PMA
qPCR method is a very useful method for studying polymicrobial
biofilms. The inclusion of a PMA-treatment step is important
for accurate qPCR based enumeration, removing non-viable
A. fumigatus and P. aeruginosa from biofilms and resulting in
a more accurate count of viable pathogens. The qPCR-PMA+
assays offer a valuable diagnostic tool and could prove useful
in monitoring the pathogen bioburden during/post antibiotic
treatment. Overall, these reductionist approaches would be
enhanced via microscopic analysis of co-cultured biofilms of
these two organisms in a flow cell system (Murphy and Caraher,
2015).
We observed that A. fumigatus CSNs inhibited P. aeruginosa
biofilm formation and this has not been shown previously.
A. fumigatus hyphae produce a number of toxins including
helvolic acid, fumagillin and gliotoxin (Amitani et al., 1995;
Hogan et al., 1996). Increased concentrations of these toxins in
48 h and 72 h CSN may account for the increased inhibitory
effect on P. aeruginosa biofilms. Manavathu and Vazquez
(2014) examined the antibacterial activity of A. fumigatus
CSN on P. aeruginosa planktonic growth and showed that at
48 h A. fumigatus CSN contained a heat stable compound
which inhibited P. aeruginosa growth in a bacteriostatic
fashion (Manavathu and Vazquez, 2014). We demonstrate that
A. fumigatus produces an anti-pseudomonal and anti-biofilm
agent at 48 h and 72 h of growth. Gt is a redox-active metabolite
that is produced by A. fumigatus at 48 h and 72 h (Reeves et al.,
2004), and its biosynthesis is directed by the gli gene cluster.
Employing a gli gene mutant strain of A. fumigatus, we showed
that CSNs from the mutant strain did not possess any inhibitory
qualities against P. aeruginosa and exposure to CSNs from the
complement strain restored inhibition suggesting gliotoxin is the
main inhibitory agent secreted by A. fumigatus.
Gt belongs to the epipolythiodioxopiperazine class of
secondary metabolites produced by A. fumigatus and
it is characterized by a disulfide bridge known to be
essential for activity (Chai and Waring, 2000). Gt displays
immunosuppressive properties (Sutton et al., 1994; Schlam et al.,
2016) and was previously considered for treatment of bone
marrow transplant patients (Müllbacher et al., 1987; Mullbacher
et al., 1988). Gt can also inhibit macrophage function (Bertout
et al., 2002), induce apoptotic cell death in macrophages (Waring,
1990), block T and B cell activation and generate cytotoxic cells
(Müllbacher and Eichner, 1984; Eichner et al., 1986; Sutton et al.,
1996). Gt and its analogs possess antimicrobial activity against
a number of microorganisms including methicillin-resistant
S. aureus, extended-spectrum beta-lactamase-producing E. coli,
vancomycin-resistant Enterococcus faecalis and C. albicans
(Li et al., 2006; Svahn et al., 2012). While Gt would be too
toxic for use as an anti-pseudomonal, Gt derivatives that
maintain anti-biofilm activity without host cell toxicity should be
evaluated. Although Gt is unlikely as a potential therapeutic, its
antimicrobial effects against multiple species demonstrated here
suggests that A. fumigatus colonization and Gt production in the
airways may cause disruption of the airway microbiome and this
is yet to be fully explored.
Co-infections with these mutual antagonists caused greater
G. mellonella mortality than single P. aeruginosa infections.
G. mellonella possess an innate immune system homologous
to that of mammals (Bergin et al., 2005). Pre-exposure of
larvae to non-lethal doses of A. fumigatus conidia increased the
mortality of G. mellonella when co-infected with P. aeruginosa
above that caused by P. aeruginosa alone. A. fumigatus
produces many immunoregulatory toxins that could suppress
the immune system of G. mellonella, making the larvae more
susceptible to P. aeruginosa infection. Gt inhibits G. mellonella
hemocyte phagocytosis and ROS formation (Renwick et al.,
2007). Alternatively, the interaction between A. fumigatus and
P. aeruginosa could cause a more virulent infection. Interestingly
the isolates, which had originally co-colonized in the same
patient showed no increase in larvae mortality when co-infecting,
suggesting that these isolates may have adapted to co-exist in
the same environment. Overall, these findings reveal bacterial–
fungal interactions may contribute to increased pathogenicity in
a strain-specific manner.
Pseudomonas aeruginosa is widely accepted to stimulate
inflammation via MAP kinase activation (Beaudoin et al.,
2013). A. fumigatus has been reported to have both pro-
inflammatory and immunosuppressive effects (Margalit
and Kavanagh, 2015; King et al., 2016; Zhang et al.,
2017). The A. fumigatus strains examined in this study
stimulated the secretion of pro-inflammatory cytokines
from CFBE cells. While it might be expected that the
combination of both pro-inflammatory pathogens would have
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an additive effect on inflammation, we have shown no additive
inflammation when cells were exposed to both A. fumigatus
and P. aeruginosa for the majority of combinations tested. We
acknowledge that these polymicrobial effects on host immune
dysregulation are likely to be quite complex, thus we attempted to
explore possible pathways for the lack of additional inflammatory
cytokine secretion. Mutual antagonism between the pathogens
may reduce the bioburden that CF lung cells were exposed to
potentially providing a benefit to the co-colonizers and/or it
may be an adaptation of the co-colonizers allowing them to co-
colonize and evade the immune system of the host and survive
in the airways. Another likely scenario is that both pathogens
saturate the ERK and p38 MAP kinase pathway for activating
cytokine production. MAPKs facilitate signaling associated with
a number of cellular activities such as cell survival, cell death,
proliferation, differentiation, and inflammation (Cowan and
Storey, 2003). In this study, we found that P. aeruginosa and
A. fumigatus both signal cytokine production in CF epithelial
cells via activation of the ERK and p38 MAP kinase pathways.
Therefore the lack of synergistic inflammatory response observed
due to co-infection may be due to saturation of signaling
pathways. The complexity of these multifactorial interactions,
will require much more examination to elucidate these pathways
and identify other potential mechanisms by which these
pathogens are able to evade the host immune system, establish
favorable conditions and chronically persist in the CF airways.
Overall, we show for the first time that P. aeruginosa and
A. fumigatus have mutually antagonistic effects at the formation
stage of biofilm development in the mixed species biofilm. Other
studies have noted the anti-fumigatus effects of P. aeruginosa
in planktonic (Briard et al., 2016) and biofilm (Mowat et al.,
2010; Briard et al., 2015; Ferreira et al., 2015; Shirazi et al.,
2016) forms of growth, however, it has not been previously
shown that P. aeruginosa also suffers from this cross-kingdom
interaction. Gt secreted by A. fumigatus is anti-pseudomonal and
anti-biofilm and could be investigated with a view to finding safer
analogs as therapeutics against antibiotic resistant biofilms in CF
airway infections and many other infections. Bacterial–fungal
interactions may also contribute to increased pathogenicity,
which could have a significant impact on the treatment of these
pathogens in patients with CF. These co-infecting microbes
contribute to an altered inflammatory response that could aid
evasion of the immune system and chronic colonization resulting
in detrimental effects on a CF patient’s health status.
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